Immobazyme was established in December of 2019, sparked by the relationship between our three co-founders and fuelled by the confidence of a few beers and scientific discussions.
These discussions quickly became the Stellenbosch University start-up that Immobazyme is today, driven with the mission of pioneering and catalysing the African biotechnology industry.
By developing innovative enzyme immobilisation platforms, we aim to create high-value products capable of solving a range of relevant industrial issues.
Dominic received his undergraduate from Stellenbosch University in BSc Molecular Biology and Biotechnology. This was then followed by a BSc (Hons) in Plant Biotechnology at the Institute of Plant Biotechnology at Stellenbosch University.
Currently, he is in his final year of his MSc in Microbiology. His masters research focuses on the development of point-of-care diagnostic biosensors for the real-time detection of bacterial pathogens. This expertise includes the use of advanced cloning and protein expression techniques to produce bacteriophage receptor binding protein based bioprobes.
These probes could efficiently and specifically tag, identify and differentiate Escherichia coli and Listeria monocytogenes.
Co-founder and CEO
Co-founder and COO
Ethan received his undergraduate BSc in Molecular Biology and Biotechnology from Stellenbosch university. This laid a foundation for his postgraduate BSc Hons in Plant Biotechnology at the Institute of Plant Biotechnology at Stellenbosch University.
Ethan then subsequently went on to receive his MSc (cum laude) in Plant Biotechnology, with a focus on ethnopharmacology and biochemical analyses of medicinal plant extracts, as well as their potential efficacy in treating chronic human diseases.
Co-founder and CTO
Nick received his undergraduate in BSc Molecular Biology and Biotechnology from Stellenbosch University.
After taking a year off as a brewer, he came back to further his studies with the completion of his BSc Hons and MSc in Biotechnology at the Institute of Plant Biotechnology. Here he focused on yeast and bacterial expression systems, protein expression, and in vitro enzyme assays.
Dr Madelein Kleyn
Dr Madelein Kleyn has more than 27 years’ experience as an international intellectual property practitioner, patent attorney and in-house legal corporate counsel in the petrochemical and agricultural industries.
She is currently Director: Technology Transfer at Innovus, Stellenbosch University, and CEO and founder of Mad K IP Consulting (Pty) Ltd, a private company advising clients on intellectual property matters. She is a qualified chemical engineer (BSc Chem Eng), an admitted attorney of the High Court of South Africa, a registered South African patent attorney and a registered technology transfer professional. She holds an LLM in tax law and a PhD in intellectual property law.